Category Archives: Biotechnology

NIGERIAN TRIBUNE (press release) (blog) [ April 25, 2017 ] World Earth Day: Stakeholders canvass for adoption of biotechnology for food security Agriculture NIGERIAN TRIBUNE (press release) (blog) The Head of Agriculture Division of the ECOWAS Commission, Ernest Aubee, who spoke with Nigerian Tribune, said the ECOWAS has a biotechnology technology action plan which it is currently implementing across the 15 member states. The Nigerian ... Read the original: [ April 25, 2017 ] World Earth Day: Stakeholders canvass for adoption of biotechnology for food security Agriculture - NIGERIAN TRIBUNE (press... … Continue reading →

DUBLIN, Apr. 24, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Biotechnology Reagents Market 2017-2021" report to their offering. Research and Markets Logo The global biotechnology reagents market to grow at a CAGR of 10.13% during the period 2017-2021. The report, Global Biotechnology Reagents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Ready-to-use reagents help minimize calculation, dilution, and pipetting errors. They reduce the duration of the diagnostic procedure and prevent contamination of samples. These factors have resulted in the demand for ready-to-use reagents among clinical laboratories and hospitals. According to the report, the biotechnology industry is spending a huge amount on R&D to innovate new techniques and technologies. The companies are more focused to improve the products, their quality, and standards. The biotech companies are majorly spending on protein synthesis, drug assessment, therapeutics, DNA and RNA analysis, and cell culture applications. Biotechnology reagents are used in all the processes. Further, the report states that biotechnology instruments are often … Continue reading →

LONDON, UNITED KINGDOM--(Marketwired - Apr 24, 2017) - Planda Biotechnology, Inc. (OTCQB: PLPL) ("Planda" or "the Company"), producer of the highly bioavailable Phytofare Catechin Complex, today announced that NutriBullet SuperFood Fat Burning Boost featuring Planda's Phytofare Catechin Complex will be available at retail outlets across the United States as early as May 2017.As announced last November, Capital Brands, the makers of NutriBullet SuperFoods, will now be featuring Planda's Phytofare Catechin Complex as the active ingredient in their product, SuperFood Fat Burning Boost.Capital Brands is expected to launch the revised product containing Phytofare with their retailers and on their website (nutriliving.com) as early as next month. Callum Cottrell-Duffield, Chief Operating Officer for Planda Biotechnology, commented, "We are excited to have Phytofare associated with such a fantastic brand as Nutribullet. Their use of Phytofare as an active ingredient in their reformulation is a clear indication of their commitment to use only the best ingredients to ensure that their customers receive a supremely effective product. It is also testimony to our shareholders that we are indeed on the right track and that our Phytofare ingredients are game changers for the supplement industry." NutriBullet has formulated specialized, plant-based SuperFood products using a variety of … Continue reading →

Two years after the $9 billion start-up unicorn Theranos crumbled, Silicon Valley still appears to be struggling to learn its lesson when it comes to health and medical start-ups. Improbable-sounding companies continue to turn up with tens of millions of dollars in funding, no published research to back them up, and nothing but criticism from scientists. Venture-capital firms insist that the standard that needs to be met for investment is much higher for medical start-ups, which must prove that their technology works with data, not just a pitch. And yet somehow, when these start-ups finally surface to public consciousness, they dont appear to pass even the most basic smell test with literally any experienced researcher in the field. There is a pervasive sense in Silicon Valley, bolstered by ten years of world-conquering success, that any sufficiently intelligent, sufficiently driven person can will what they want. But the move fast and break things mantra that has helped Silicon Valley disrupt countless industries over the last two decades is more dangerous when applied to medical scienceThe things being broken by health start-ups are laws of science and ironclad guidelines for research. When a health start-up moves fast and breaks things, it can … Continue reading →

BBNS Vetr Inc. Downgrades iShares NASDAQ Biotechnology Index (IBB ... The Cerbat Gem iShares NASDAQ Biotechnology Index (NASDAQ:IBB) was downgraded by Vetr from a buy rating to a hold rating in a research note issued to investors on ... iShares NASDAQ Biotechnology Index (IBB) Earning Favorable ...BBNS all 4 news articles » Read the original: Vetr Inc. Downgrades iShares NASDAQ Biotechnology Index (IBB ... - The Cerbat Gem … Continue reading →

CRISPR is a gene-editing tool that enables scientists to do things like turn off the enzyme that makes mushrooms turn brown when bruised or cut. Brand X Pictures/Thinkstock In April 2016, an unlikely thing made headlines: the common white button mushroom. Gene-Edited CRISPR Mushroom Escapes US Regulation, wrote Nature. Whats a GMO? Apparently Not These Magic Mushrooms, wrote Grist. And from MIT Technology Review: Who Approved the Genetically Engineered Foods Coming to Your Plate? No One. The white button mushroom in question looked like any other in the grocery store, with one imperceptible difference: It was missing a gene that codes for an enzyme called PPO, or polyphenol oxidase, which makes mushrooms turn brown when theyre bruised or cut. Scientists at Pennsylvania State University essentially turned off this PPO geneone of six in the mushroomwith a new gene-editing tool called CRISPR, or clustered regularly interspaced short palindromic repeats. CRISPR is a bit like a biological word processor. It zooms to a specific genetic sequence in any living thingthe biotech equivalent of using Ctrl+F. Then, the tool can add, delete, or replace genetic information like an editor tweaking a sentence. While the Penn State scientists used biotechnology to manipulate the mushrooms … Continue reading →

FARGO, N.D. Those attending the recent International Sugarbeet Institute in Fargo got a glimpse of what the future of agriculture is going to look like. That peek into the future was made possible by the keynote speaker Robert Fraley, Ph.D., the executive vice president and chief technology officer at Monsanto. In addition, he is often recognized as the father of agricultural biotechnology. In his position, Fraley has his finger on the pulse of agricultures future, which he claims is very strong and promising. Ive been doing this at Monsanto for 37 years, he said, and I would tell you today that the amount of science coming into agriculture is just stunning. I helped invent GMO. Today we are talking about the second or third generation beyond GMO. From those first Roundup Ready soybeans and BT cotton approved about 20 years ago, a wide variety of crops have been added to the list such as corn, canola, sugarbeets and alfalfa, along with many other lesser crops, he noted. Fraley feels the most important advancement of adapting GMO technology is the ability to use germplasm from all around the world. This means the next improvement in corn could easily come from a … Continue reading →

Breaking Finance News iShares NASDAQ Biotechnology Index (IBB) Declares Quarterly Dividend of $0.30 The Cerbat Gem iShares NASDAQ Biotechnology Index logo iShares NASDAQ Biotechnology Index (NASDAQ:IBB) declared a quarterly dividend on Friday, March 24th. Shareholders of record on Tuesday, March 28th will be paid a dividend of 0.299 per share by the financial ... iShares NASDAQ Biotechnology Index (IBB) Rating Increased to Buy at Vetr Inc.BBNS iShares NASDAQ Biotechnology Index (IBB) Upgraded by Vetr Inc. to BuyTranscript Daily Vetr Inc. Upgrades iShares NASDAQ Biotechnology Index (IBB) to ...Sports Perspectives Breaking Finance News all 16 news articles » More: iShares NASDAQ Biotechnology Index (IBB) Declares Quarterly Dividend of $0.30 - The Cerbat Gem … Continue reading →

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO) today announced education program session titles and speakers for the 2017 BIO World Congress on Industrial Biotechnology. The education program features seven diverse content tracks with speakers from around the world over three days of the conference. The worlds largest industrial biotechnology and partnering event will be held July 23-26, 2017 at the Palais des congrs de Montral in Montral, Qubec, Canada. Brent Erickson, executive vice president of BIOs Industrial & Environmental Section, stated, BIOs 2017 World Congress will feature the most diverse group of speakers and presenters in the conferences history, with scientists and executives from start-up companies, investors from the finance sector, consumer product manufacturers and government officials from across Canada, Europe, the United States and Asia. The education program and partnering system provide a unique forum for conference attendees to share the latest advances in renewable chemicals, synthetic biology, enzymes, food ingredients, fragrances, flavors, cosmetics, biofuels and biorefineries, agricultural crops and biobased materials. Sessions featuring Renewable Chemicals and Biobased Materials include: A Revolution in Biobased Products and Packaging Wed. July 26, 11:45 am Renewable Chemicals and Thermoplastics for Performance Materials Mon. July 24, 10:30 AM Scaling Novel and Innovative Processes for … Continue reading →

OTTAWA, Ontario--(BUSINESS WIRE)-- BioTalent Canada announced today that its animated short, Expanding Accessibility in Biotechnology, has won the Platinum Award for Motion Graphics Information at the 2017 Hermes Creative Awards, an international competition overseen by the Association of Marketing and Communications Professionals (AMCP). The award showcases the talent and creativity of marketing and communications professionals, many of whom have contributed to public service or charitable organizations. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170420005937/en/ Expanding Accessibility in Biotechnology was created as part of BioTalent Canadas Accessibility for Ontarians with Disabilities Act (AODA) employer-awareness campaign, launched in 2016 and funded in part through the Government of Ontarios EnAbling Change Program. The campaign aims to reach and educate bio-economy employers on compliance with the new AODA accessibility standards. As a national non-profit HR association for the Canadian biotechnology industry, BioTalent Canada works to ensure that the bio-economy has access to the talent it needs. According to research by the organization, only 7.6% of bio-economy companies had persons with disabilities on staff. BioTalent Canadas animation seeks to increase awareness among employers on the importance of persons with disabilities as a strategically valuable labour market for Canadas biotechnology sector. Developed … Continue reading →